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Abstract 
Background 
This study aimed to systematically review the evidence from randomized controlled trials 
(RCTs) and to conduct a meta-analysis of the effects of yoga on physical and psychosocial 
outcomes in cancer patients and survivors. 
Methods 
A systematic literature search in ten databases was conducted in November 2011. Studies 
were included if they had an RCT design, focused on cancer patients or survivors, included 
physical postures in the yoga program, compared yoga with a non-exercise or waitlist control 
group, and evaluated physical and/or psychosocial outcomes. Two researchers independently 
rated the quality of the included RCTs, and high quality was defined as >50% of the total 
possible score. Effect sizes (Cohen’s d) were calculated for outcomes studied in more than 
three studies among patients with breast cancer using means and standard deviations of post-
test scores of the intervention and control groups. 
Results 
Sixteen publications of 13 RCTs met the inclusion criteria, of which one included patients 
with lymphomas and the others focused on patients with breast cancer. The median quality 
score was 67% (range: 22–89%). The included studies evaluated 23 physical and 20 
psychosocial outcomes. Of the outcomes studied in more than three studies among patients 
with breast cancer, we found large reductions in distress, anxiety, and depression (d = −0.69 
to −0.75), moderate reductions in fatigue (d = −0.51), moderate increases in general quality 
of life, emotional function and social function (d = 0.33 to 0.49), and a small increase in 
functional well-being (d = 0.31). Effects on physical function and sleep were small and not 
significant. 
Conclusion 
Yoga appeared to be a feasible intervention and beneficial effects on several physical and 
psychosocial symptoms were reported. In patients with breast cancer, effect size on 
functional well-being was small, and they were moderate to large for psychosocial outcomes. 
Keywords 
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Background 
Cancer represents a major public health concern. In Western countries, approximately one in 
three persons will be directly affected by cancer before the age of 75 years, with breast 
cancer, melanoma, colorectal cancer and prostate cancer comprising the most common types 
[1,2]. Due to medical advances, survival rates have improved over the past decade. For 
example, currently, the 5-year survival rates across all cancers are approximately 56% for 
male and 62% for female patients in Australia [1] and 58% and 64%, respectively, in the 
Netherlands [2]. However, cancer and its treatment are often associated with prolonged 
adverse physical and psychosocial symptoms, including reduced physical function and fitness 
and increased risk of anxiety, depression, and fatigue [3,4]. This greatly impacts the patient’s 
quality of life (QoL) [5,6]. Therefore, there is a need for effective methods to manage 
physical and psychosocial symptoms and to improve QoL of cancer patients and survivors. 
Psychosocial interventions such as counselling, support groups and cognitive behavioural 
therapies may help patients cope with cancer and the psychosocial problems associated with 
cancer and cancer treatment, but are less likely to help with common physical issues such as 
loss of strength and flexibility, weight gain, and reduced physical function [7]. Findings from 
previous reviews and meta-analyses suggest that aerobic and resistance exercise attenuate a 
range of the physical problems associated with cancer and cancer treatment [3,4,6,8-16]. The 
benefits of these types of exercise include not only improved physical function, but also 
reduced fatigue and improved QoL. Unfortunately, many cancer patients perceive various 
barriers to exercise [17-21]. The most common physical barriers are physical discomfort and 
feeling sick. Psychosocial barriers include having low mood, feelings of self-consciousness 
relating to appearance and body image, fatigue and fear for overdoing it [20,22,23]. Because 
of these barriers, approximately one out of three adult cancer patients turns to complementary 
and alternative medicine techniques, mindfulness, or yoga, to help manage their symptoms 
[24-26]. 
Yoga is a ‘mind-body’ exercise, a combination of physical poses with breathing and 
meditation [27]. Several studies in the non-cancer population reported positive effects of 
yoga on physical outcomes including perceptual and motor skills [28], cardiopulmonary 
function [29], fitness [30], muscle strength, flexibility, stiffness, and joint pain [31-33]. 
Furthermore, a recent review of 10 studies comparing the effects of yoga asanas (postures) 
with those of ‘regular’ exercise, indicated that yoga may be as effective as exercise for 
improving health outcomes such as blood glucose and lipids, fatigue, pain, and sleep in 
healthy people and in people with conditions such as diabetes and multiple sclerosis [34]. 
Previous reviews [35,36] and a meta-analysis [37] of intervention studies have reported that 
yoga is feasible for patients with cancer, with improved sleep, QoL, mood and levels of 
stress. The current study extends previous work by our exclusive focus on 1) randomised 
controlled trials (RCTs), the most rigorous intervention study design; 2) yoga interventions 
that included physical postures and were not part of a larger program such as Mindfulness-
Based Stress Reduction; and 3) a focus on both physical and psychosocial outcomes. 
The aim of the present study is to conduct a systematic review and meta-analysis of the 
effects of yoga in cancer patients and survivors, focusing on both physical and psychosocial 
outcomes. 
Methods 
Literature search 
IR, medical librarian, conducted the literature search in ten databases: AgeLine and AMED 
(Allied and Complementary Medicine Database), British Nursing Index, CINAHL, 
CENTRAL (The Cochrane Central Register of Controlled Trials), EMBASE, PEDro, 
PsycINFO, PubMed and SPORTDiscus (earliest to November 2011). In order to identify all 
relevant papers, a search was conducted with both thesaurus terms and free terms for ‘yoga’ 
in combination with an extensive list of search terms to identify intervention studies. RCTs 
were identified using search terms for certain publication types (e.g. randomized controlled 
trial and controlled clinical trial in PubMed) in combination with a list of free text terms in 
title and abstracts that could be used to describe RCTs (e.g. randomi*ed, randomly, trial, 
groups). Detailed search profiles are available on request from IR. Additional articles were 
identified by manually checking the reference list of included papers. 
Study inclusion criteria 
Study inclusion criteria were: (i) design: RCT; (ii) population: adults with any cancer 
diagnosis either during or post treatment; (iii) intervention: yoga including physical postures 
(asanas); (iv) control group: non-exercise or wait-list; (v) outcome: physical and psychosocial 
outcomes. Only full-text articles written in English were included. Studies that included yoga 
as part of a larger intervention program (e.g., Mindfulness-Based Stress Reduction, 
meditation, or pranayama (breathing control) only) were excluded. 
Selection process and quality assessment 
Titles and abstracts of the references were reviewed to exclude articles out of scope (JvU). 
Full-text articles of potentially relevant records were assessed for eligibility by two 
independent reviewers (LB and JvU). 
LB and JvU independently assessed the quality of the included papers using a Delphi list 
developed by Verhagen et al. [38], which consists of nine equally weighted quality criteria to 
assess different methodological aspects (see below). This list has previously been used for the 
evaluation of methodological quality in systematic reviews of exercise programs [39-41]. 
Criteria have a ‘yes’ (=1), ‘no’ (=0) or ‘don’t know’ (=0) answer format. Disagreements 
between the reviewers were discussed and resolved, and in case of doubt, a third reviewer 
(MC) was consulted. Authors were contacted for additional information if it was not possible 
to score an item based on the information provided in the paper. Items scoring a “yes” 
contribute to the quality scores, ranging from 0 to 9 points. Where outcomes were assessed 
by self-report only, criterion 5 (blinding of the outcome assessor) was not applicable, and 
studies could obtain a maximum quality score of 8 points. A study was classified as a low 
quality study if the quality score was lower than 50% of the maximum possible score [41]. 
Criteria considered for quality assessment according to Verhagen et al. [38] 
1. Was a method of randomization performed? 
2. Was the treatment allocation concealed? 
3. Were the groups similar at baseline? 
4. Were the eligibility criteria specified? 
5. Was the outcome assessor blinded? 
6. Was the yoga instructor blinded (i.e. unaware of the study aim)? 
7. Was the participant blinded? 
8. Were point estimates and measures of variability (between groups comparison) 
presented for the primary outcomes? 
9. Did the analysis include an intention-to-treat analysis? 
Data extraction 
The following data were extracted by LB: (i) study population; (ii) type, intensity, frequency 
and duration of intervention, (iii) control group; (iv) outcome measures; and (v) effects on 
physical and/or psychosocial outcomes. 
Meta-analysis 
Effect sizes were calculated (standardized mean difference d) for all individual studies by 
subtracting the average post-test score of the control group (Mc) from that of the yoga 
intervention group (My) and dividing the result by the pooled standard deviations of the yoga 
intervention group and the control groups (SDyc) [42]. An effect size of 0.5 thus indicates 
that the mean of the experimental group is half a standard deviation larger than the mean of 
the control group. Effect sizes of 0.56 to 1.2 are large, while effect sizes of 0.33 to 0.55 are 
moderate and effect sizes of 0 to 0.32 are small [43]. 
For outcomes that were investigated in >3 studies, individual effect sizes were pooled in 
Comprehensive Meta-Analysis (CMA; version 2.2.046). Because only one study did not 
include patients with breast cancer [44], the meta-analyses was conducted on data from 
studies including patients with breast cancer only. As we expected considerable 
heterogeneity, we calculated pooled effect sizes with the random effects model. This model 
assumes that the included studies are drawn from ‘populations’ of studies that differ from 
each other systematically (heterogeneity). In this model, the prevalence resulting from the 
included studies not only differs because of the random error within studies (fixed effects 
model), but also because of true variation in prevalence from one study to the next. We first 
tested the heterogeneity under the fixed model using the statistics I2 and Q. I2 describes the 
variance between studies as a proportion of the total variance. A value of 0% indicates no 
observed heterogeneity, and larger values show increasing heterogeneity, with 25% as low, 
50% as moderate, and 75% as high heterogeneity [45]. When P values of the Q are above 
0.05, the total variance is due to variance within studies and not to variance between studies. 
We ran the analyses on all studies and with outliers excluded. Studies with extreme values of 
which the 95% confidence interval had no overlap with the 95% confidence interval of the 
pooled estimate were considered as outliers. 
Results 
After removing duplicates, the literature searches yielded a total of 1909 unique records. For 
171 potentially relevant records, we checked full text (Figure 1). The majority of the studies 
(n = 79) were excluded because they were not designed as a RCT. Of the records identified in 
the database search, 15 records met the inclusion criteria. We found one additional RCT [31] 
from the reference list of the review by Smith and Pukall [35]. Both Vadiraja et al. [46-48] 
and Raghavendra et al. [49,50] published more than one paper on the same RCT, each 
describing different outcome measures and/or subpopulations. Thus 16 papers [31,32,44,46-
58] of 13 RCTs were included in this systematic review. Details of the populations, yoga 
interventions, and outcomes of the included studies are presented in Tables 1, 2 and 3. 
Figure 1 Flow chart 
Table 1 Description of study populations in alphabetical order of first author 
Author, year Diagnosis; treatment number of participants (n); 
gender (%women); mean 
age (sd) and/or range 
eligibility criteria 
Banasik, 2011 
[56] 
Breast cancer,  
(>2 mo) post-treatment 
n = 18 (9Y, 9C) 
% women: 100% 
Age: 62.9 (7.1) years 
Inclusion women with stages II-IV breast cancer at least 2 months post-treatment. 
Exclusion receiving Herceptin therapy, pregnant or lactating, had past or current 
history of other neoplasm, active serious infection or immune deficiency; history of 
psychiatric disorders or alcohol or drug abuse; steroid therapy or physical condition 
preventing yoga. 
Banerjee, 2007 
[51] 
Breast cancer, 
during radiotherapy 
n = 58 (35Y, 23C) 
% women: 100% 
Age: 44 (1.3) years 
Inclusion Recently operated breast cancer, age between 30 and 70 years, Zubrod’s 
performance status 0–2 (ambulatory >50% of the time), high school education, 
treatment plan of radiotherapy or both radiotherapy and chemotherapy, consent to 
participate in the study. 
Exclusion Having any concurrent medical condition likely to interfere with the 
treatment; major psychiatric, neurological illness, or autoimmune disorders; 
cardiovascular illness; any known metastases. No exposure to other mutagens, 
smoking or alcohol for at least 3 months prior to pre-radiation blood donation. 
Blank, 2003 
[31] 
Breast cancer stage I-III 
receiving antiestrogen or 
aromatase inhibitor 
hormonal therapy 
N = 18 (9Y, 9C) 
% women: 100% 
Age: 48 – 69 years 
Inclusion minimum of eight weeks post chemotherapy, estrogen receptor positive 
status, surgery for lumpectomy, modified mastectomy or full mastectomy 
(with/without reconstruction), a life expectancy greater than six months, adequate 
blood cell counts and kidney, liver, and cardiac function, physical and mental 
ability to attend all the Yoga training sessions. 
Exclusion women on Herceptin therapy, current steroid therapy, or other known 
immunomodulating medications, pregnancy or current lactation, a past or current 
history of another neoplasm, active serious infection or immune deficiency, 
documented alcohol or drug abuse, history of psychiatric disorders requiring use of 
psychotropic medication. 
Bower, 2012 
[58] 
Breast cancer state 0 – II, 
at least 6 months after 
adjuvant cancer therapy. 
n = 31 (16Y, 15C) 
% women: 100% 
Age: 54.4 (5.7) years 
Inclusion originally diagnosed with stage 0 to II breast cancer; completed local 
and/or adjuvant cancer therapy (with the exception of hormone therapy) at least 6 
months previously; ages 40 to 65 years; postmenopausal; no other cancer in last 5 
years; experiencing persistent cancer-related fatigue. 
   Exclusion chronic medical conditions or regular use of medications associated with 
fatigue; evidence that fatigue was driven primarily by a medical or psychiatric 
disorder other than cancer; evidence that fatigue was driven primarily by other 
noncancer-related factors; physical problems or conditions that could make yoga 
unsafe; a body mass index (BMI) >31 kg/m2. 
Carson, 2009 
[32] 
Breast cancer; no current 
treatment  
(4.9 ± 2.4 years since 
diagnose) 
n = 37 (17Y, 20C)  
% women: 100%  
Age: 54.4 (7.5) years 
Inclusion Experiencing at least one hot flash per day on 4 or more days per week; 
no signs of active breast cancer; no current cytotoxic chemotherapy; diagnosed with 
breast cancer at stages IA-IIB ≥ 2 years before; no hormone replacement therapy 
currently or within prior 3 months; stabilized on constant regime of menopausal 
symptom medications and supplements for at least 3 weeks; if taking 
antidepressants, stabilized at a fixed dose for at least 3 months. 
Exclusion resided ≥ 70 miles from research site; unavailable to attend the 
intervention on the day and at the time offered; currently engaged in intensive yoga 
practice (> 3 days/week); having received treatment for serious psychiatric 
disorders (e.g. schizophrenia) in the previous 6 months; not English speaking 
Chandwani, 
2010 [55] 
Breast cancer, during 
radiotherapy 
N = 61  
% women: 100% 
Age: 51.4 (8.0) range 37–68 
years 
Inclusion Women with stage 0-III breast cancer; ≥ 18 years; able to read, write and 
speak English; scheduled to undergo radiotherapy. 
Exclusion Patients who had any major psychiatric diagnosis or physical limitations 
that would prohibit participation in the yoga program. 
Cohen, 2004 
[44] 
Lymphoma (18% 
Hodgkin),  
61,5% active treatment 
n = 39  
% women: 61.5%  
Age: 51 years 
Inclusion Patients with lymphoma who were either receiving chemotherapy or had 
received it within the past 12 months; ≥ 18 years; able to read and speak English. 
Exclusion Patients with major psychotic illnesses. 
Culos-Reed, 
2006 [52] 
Breast cancer (85%); no 
current treatment  
(> 3 mo post-treatment) 
n = 38 
% women: 95%  
Age: 51.2 (10.3) years 
Inclusion Cancer survivors who were currently not undergoing active treatment; no 
additional health concerns; ≥ 18 years; minimum 3 months post-treatment. 
Danhauer, 2009 
[53] 
Breast cancer; 34% 
actively undergoing 
treatment 
n = 44 
% women: 100%  
Age: 55.8 (9.9) years 
Inclusion Women ≥ 18 years; diagnosed with breast cancer; 2 to 24 months post-
primary treatment (surgery) following initial diagnosis and/or had a recurrence of 
breast cancer within the past 24 months (regardless of treatment status); physically 
able to attend restorative yoga; able to understand English; free of medical 
contraindications reported by their physician. 
Littman, 2011 
[57] 
Breast cancer; > 3 mo 
post-treatment 
n = 63 
% women: 100%  
Age: 60 (7.9) years 
Inclusion Age between 21 and 75 years; completion of breast cancer treatment 
(stage 0-III) at least 3 months prior, BMI ≥24 kg/m2 (or ≥23 kg/m2 if of Asian 
descent). 
   Exclusion Myocardial infarction or stroke in the previous 6 months, diabetes, 
current yoga practice, pregnancy or plans to become pregnant, factors that might 
lead to poor retention and yoga practice. 
Moadel, 2007 
[54] 
Breast cancer; 48% 
medical treatment 
n = 128 
% women: 100%  
Age: 54.8 (9.9) range 28–75 
years 
Inclusion Age ≥ 18 years; new/recurrent breast cancer (stages I-III) diagnosis 
within previous 5 years; high performance status (Eastern Cooperative Oncology 
Group performance status of < 3); ability to speak English or Spanish; not actively 
practicing yoga. 
Raghavendra, 
2007 [49] 
Breast cancer, during 
chemotherapy 
n = 62 
% women: 100%  
Age: n = 33 < 50 yrs; n = 29 > 
50 yrs 
Inclusion Recently diagnosed with operable breast cancer; aged between 30 and 70 
years; Zubrod’s performance status 0–2; high school education; having a treatment 
plan with surgery followed by adjuvant chemotherapy or by both adjuvant 
radiotherapy and chemotherapy; consenting to participate in the study. 
Exclusion history of intestinal obstruction and any known sensitivity to any class of 
antiemetics. 
Rao, 2009 [50] Breast cancer, during 
adjuvant chemotherapy 
and radiotherapy 
n = 98;  
% women: 100%  
Age: ? 
Inclusion Recently diagnosed with operable breast cancer; aged between 30 and 70 
years; Zubrod’s performance status 0–2; high school education; having a treatment 
plan with surgery followed by adjuvant radiotherapy and chemotherapy; consenting 
to participate in the study. 
Exclusion Having a concurrent medical condition likely to interfere with the 
treatment; any major psychiatric, neurological illness or autoimmune disorders; 
secondary malignancy. 
Vadiraja, 2009 
[46-48] 
Breast cancer (stage II 
and III), during adjuvant 
n = 88;  
% women: 100%  
Age: 46 (9.1) yrs yoga; 48.4 
(10.2) yrs C. 
Inclusion Recently diagnosed with operable breast cancer; aged between 30 and 70 
years; Zubrod’s performance status 0–2; high school education; having a treatment 
plan with surgery followed by adjuvant chemotherapy or by both adjuvant 
radiotherapy and chemotherapy; consenting to participate in the study. 
Exclusion Having a concurrent medical condition likely to interfere with the 
treatment; any major psychiatric, neurological illness or autoimmune disorders; any 
known metastases; prescribed concurrent chemotherapy cycles during radiotherapy. 
  
Table 2 Description of yoga programs, in alphabetical order of first author and attendance to yoga class 
Author, year Yoga program (Y); Duration and frequency (D); Home practice (H) vs comparison (C) Attendance 
Banasik 2011 [56] Y Iyengar yoga given by expert Iyenger instructors, with focus on training and accepting the 
physical form of the body without specific meditation component. 
Average 14 classes out of 16 
(87.5%), range 12 – 15. 
D 8 weeks, twice a week, 90 min per session 
H - 
C wait-list 
Banerjee, 2007 [51] Y Meditative practice, slow stretching and loosening exercises, motivation and counseling, yoga 
asanas, group awareness practices, pranayama, deep relaxation (yoga nidra) given by expert yoga 
trainers. 
? 
D 6-weeks; 90 min per session 
H Patients were provided with audio and video tools to practice at home and were followed up via 
telephone during weekends to ensure continuity of the practice. 
C Supportive counseling and advised to take light exercise. 
Blank, 2003 [31] Y Iyengar Yoga, including seated meditation, active asana, restorative poses, savasana. ? 
D 8 weeks, 2 times per week 
H 1 home practice per week 
C wait-list control 
Bower, 2012 [58] Y Iyengar yoga classes were taught by a certified Junior Intermediate Iyengar yoga instructor and an 
assistant under the guidance of a senior teacher. 
The mean number of yoga classes 
attended was 18.9 of 24 classes 
(78%), and the median was 22 of 
24 classes (92%). 
D 12 weeks, twice a week, 90 min. 
H - 
C Health education classes were conducted for 120 min once a week for 12 weeks. Classes were led 
by a PhD-level psychologist with clinical experience in the treatment of breast cancer survivors. 
Carson, 2009 [32] Y Yoga of Awareness given by certified yoga teacher: 40 min yoga poses, 10 min breathing 
techniques, 25 min meditation, 20 min of study pertinent topics and 25 min group discussion 
Average 6 classes out of 8 (75%). 
3 women less than 4 classes (3/17 
= 17.6%) D 8 weeks, once a week, 120 min 
H Patients were encouraged to practice daily at home with aid of CD recordings and illustrated hand 
books. 
C Wait-list control 
Chandwani, 2010 [55] Y The multidimensional yoga module was given a trained yoga instructor: 10 warm-up movements 
synchronized with breathing, 25 min maintenance in selected postures, 10 min deep relaxation, 5 
min pranayama, 10 min mediation. 
15 (50%) all 12 classes; 8 (28%) 
attended 11 classes; 1 (3%) 
attended 10 classes; 1 only 2 
classes. One attended 3 classes, 
one 4, one 5, one 7 and one 8 
classes. Average number of 
classes was 10.2 (85%); SD: 
2.96; range 2 – 12. Home 
practice: 8 (28%) reported 
practicing 
D 6 weeks, 2 times per week; 60 min per session 
H Patients were encouraged to practice type full yoga once per day outside the classes, supported by 
a 60-min audio CD of the yoga program and a manual with photographs and instructions. 
C Wait-list control 
Cohen, 2004 [44] Y Tibetan yoga sessions given by experienced instructor, divided into 4 aspects: controlled breathing 
and visualization, mindfulness, and postures. 
32% all sessions; 26% 5 or 6 
sessions; 32% 2 or 3 sessions; 
10% 1 session D 7 weekly sessions 
H Patients were encouraged to practice the techniques at least once per day, supported by audiotape 
that walked them though all of the techniques. 
C Wait-list control 
Culos-Reed, 2006 [52] Y Classes were led by a certified yoga instructed and included 10 min gentle breathing; 50 min Yoga 
asanas; 15 min savasana. 
 
D 7 weeks, 75 min. 
H - 
C Wait-list control 
Danhauer, 2009 [53] Y Restorative yoga classes were taught by a yoga instructor with cancer-specific yoga training and 
combined yoga asanas, pranayama, savasana. 
Mean 5.8 (3.4) classes out of 10 
(58%) 2 (10%) women 100%; 3 
(14%) 0% of classes D 10 weekly 75-min classes 
H - 
C Wait-list control 
Littman, 2011 [57] Y Viniyoga, a Hatha therapeutic type o f yoga given by certified experienced yoga instructors: 5–10 
min centering exercises to promote relaxation and internal focus, 50–60 min of seated and standing 
poses, 10–15 min guided relaxation, breathing exercises and meditation. 
Mean 19.6 (range 1–61; median 
20.5) classes. Home practice: 
55.8 times (range 2 – 102; 
median 62). D 6 months, 5 times per week including at least one 75-min class 
H patients were given a DVD, VD and booklets of four home practices lasting 20–30 min each. 
C Wait-list control 
Moadel, 2007 [54] Y Classes were given by a certified yoga instructor and included 3 yoga components: physical 
stretches and poses, breathing exercises, and meditation. 
High adherence (>6 classes): n = 
33 (; Low adherence (1–6 
classes), n = 24; No adherence (0 
classes), n = 27. Average 
attendance 7 out of 12 classes 
(58%). 
D 12 weekly 1.5 hrs classes (more allowed) 
H Patients were asked to practice yoga at home daily and given an audiotape/compact disk for 
guidance. 
C Wait-list control 
Raghavendra, 2007 [49] Y Integrated yoga program administered by an instructor: asanas, breathing exercise, pranayama, 
meditation and yogic relaxation techniques with imagery. 
? 
D 30 min before the start of the chemotherapy infusion (once in 10 days, number of cycles 4–8). 
H Patients were provided with audiotapes of these exercises for home practice and asked to practice 
daily for 1 h for 6 days/week during intervals between chemotherapy cycles. 
C Supportive therapy and coping preparation 
Rao, 2009 [50] Y Integrated yoga program administered by an instructor: asanas, breathing, pranayama, mediation 
and yogic relaxation techniques with imagery. 
? 
D Four sessions during pre- and post operative period, 3 in-person sessions per week for 6 weeks 
during radiotherapy. During chemotherapy, subjects underwent person sessions during their hospital 
visits for chemotherapy administration (once in 21 days) and an additional yoga session once in 10 
days. 
H Patients were given booklets, audiotapes with instructions on practices for home practice. 
C Supportive therapy sessions 
Vadiraja, 2009 [46-48] Y Integrated yoga program administered by an instructor: asanas, breathing, pranayama, mediation 
and yogic relaxation techniques with imagery. 
29.7% attended 10-20% 
supervised sessions, 56.7% 
attended 20–25, 13.7% attended 
>25 supervised sessions over a 6-
week period. Attend minimal 
3x/wk for 6 weeks → 18 classes. 
D Minimum of 3 in-person sessions per week for 6 weeks during radio treatment; 1 hour per session. 
In total between 18–24 yoga sessions. 
H Patients were given booklets, audiotapes with instructions on practices for home practice. 
C Supportive therapy with education. 15-min counseling sessions once every 10 days during 6 
weeks (3 or 4 sessions in total). 
Asana = physical posture; Pranayama = breathing practice, voluntary regulated nostril breathing; Yoga nidra = deep relaxation; Savasana = the corpse pose, 
relaxation. 
  
Table 3 Description of physical and psychosocial outcomes and between group differences (yoga vs control), in alphabetical order of 
first author 
Author, year Physical Outcomes Between group difference Psychosocial Outcomes Between group difference 
Banasik, 2011 
[56] 
FACT  FACT  
- Physical well-being N.S. - emotional well-being N.S. 
- Functional well-being N.S. - social well-being N.S. 
Cortisol, morning N.S. Breast cancer concerns N.S. 
Cortison, noon P = 0.004 Fatigue P = 0.003 
Cortisol, 5 p.m. P = 0.004   
Cortisol, 10 p.m. N.S.   
Banerjee, 2007 
[51] 
DNA damage 14,5% less DNA damage in 
Yoga group; p < 0.001 
Anxiety (HADS-A) 48% reduction in yoga group vs 28% 
increase in controls; p < 0.001 
Depression (HADS-D) 57.5% decrease in yoga vs 24% decrease 
in controls; p < 0.001 
Perceived stress (PSS) 26.9% reduction in yoga vs 7% increase 
in controls; p < 0.001 
Blank, 2003 
[31] 
25% had relieved joint aches and 
shoulder stiffness 
NA 100% perceived direct stress 
reduction 
NA 
88% felt more relaxed in daily life, 
more aware of body posture, 
improved body image 
NA 
63% had improved mood and less 
anxiety 
NA 
Bower, 2012 
[58] 
Lower extremity strength and 
endurance (timed chair stands) 
1.31 (−5.00; 2.38, N.S. Fatigue (FSI) −1.24 (−0.04; -2.45), p < 0.05 
Flexibility (functional reach test) −2.00 (5.76; -9.98), N.S. Vigor 4.80 (1.86; 7.74), p < 0.05 
Depression (BDI) −5.80 (−1.74; -9.86), p < 0.05 
Sleep quality (PSQI) 0.20 (2.78; -2.38), N.S. 
Perceived stress (PSS) −1.77 (1.71; -5.26), N.S. 
 
Carson, 2009 
[32] 
Hot flash frequency P = 0.0017 Negative mood P = 0.099 
Hot flash severity P = 0.0019 Relaxation P = 0.543 
Hot flash total P < 0.0001 Vigor P = 0.005 
Joint pain P < 0.0001 Acceptance P = 0.058 
Night sweats N.S. Symptom-related bother P < 0.0001 
Fatigue P = 0.001 
Sleep disturbance P = 0.007 
Chandwani, 
2010 [55] 
SF-36  SF-36  
- Physical component summary ES = 0.44; P = 0.04 - Mental component summary N.S. 
- Physical function ES = 0.46; p = 0.04 - Mental health N.S. 
- body pain N.S. - Role physical N.S. 
- Role emotional N.S. 
- Social function N.S. 
- vitality N.S. 
- General HRQoL ES = 0,47; p = 0.005 
Depression (CES-D) N.S. 
Anxiety (STAI) N.S. 
Distress (IES)  
- Intrusion N.S. 
- Avoidance N.S. 
Fatigue (BFI) N.S. 
Sleep (PSQI) N.S. 
Benefit finding (BFS) N.S. 
Cohen, 2004 
[44] 
  Distress (IES) N.S. 
Anxiety (STAI) N.S. 
Depression (CES-D) N.S. 
Sleep disturbances (PSQI)  
- Total score P = 0.004 
- Sleep quality P = 0.02 
- Sleep latency P = 0.01 
- Sleep duration P = 0.03 
- Sleep efficiency N.S. 
- Sleep medications P = 0.02 
- Daytime dysfunction N.S. 
Fatigue (BFI) N.S. 
Culos-Reed, 
2006 [52] 
Physical activity (LSI) N.S. Mood (POMS)  
Weight N.S. - Total mood P < 0.10 
Systolic and diastolic blood 
pressure 
N.S. - Tension-anxiety P < 0.10 
Hand grip strength N.S. - Depression-dejection P < 0.10 
Distance walked N.S. - Confusion-bewilderment P < 0.10 
Perceived exertion N.S. - Vigor N.S. 
Flexibility (sit and reach) N.S. - Anger-hostility N.S. 
EORTC-QLQ-C30  Symptoms of stress (SOSI)  
- Physical function N.S. - Peripheral manifestations N.S. 
- pain N.S. - Cardiopulmonary symptoms N.S. 
- nausea and vomiting N.S. - Symptoms of arousal N.S. 
- dyspnea P < 0.05 - Upper respiratory symptoms N.S. 
- appetite N.S. - Central neurological symptoms N.S. 
- constipation N.S. - Gastrointestinal symptoms P < 0.10 
- diarrhea P < 0.05 - Muscle tension N.S. 
- Habitual patterns N.S. 
- Depression N.S. 
- Anxiety/fear N.S. 
- Emotional irritability P < 0.10 
- Cognitive disorganization P < 0.10 
HRQoL (EORTC QLQ-C30)  
- global quality of life P < 0.01 
- emotional function P < 0.05 
- cognitive function N.S. 
- social function N.S. 
- role function N.S. 
- fatigue (POMS) N.S. 
- sleep disturbance N.S. 
Danhauer, 2009 
[53] 
Physical function (SF-12) N.S. Mental health (SF-12) P = 0.004 
FACT  Depression (CES-D) P = 0.026 
- Physical well-being N.S. Fatigue (FACT-fatigue) N.S. 
- Functional well-being N.S. Negative affect (PANAS-NA) P = 0.014 
Positive affect (PANAS-PA) P = 0.01 
FACT-General P = 0.052 
- Social well-being N.S. 
- Emotional well-being P = 0.042 
Spiritual well being (FACIT Sp)  
- peace/meaning P = 0.0009 
- role of faith N.S. 
Sleep disturbances (PSQI)  
- Total score N.S. 
- Sleep quality N.S. 
- Sleep latency P = 0.078 
- Sleep duration N.S. 
- Sleep efficiency N.S. 
- Sleep medications P = 0.10 
- Daytime dysfunction N.S. 
Littman, 2011 
[57] 
FACT  Overall QoL (FACT-G) N.S. 
- Physical well-being N.S. Breast-cancer subscale N.S. 
- Functional well-being N.S. - Social well-being N.S. 
Physical Activity (MAQ) N.S. - Emotional well-being N.S. 
BMI N.S. - social/family well-being N.S. 
Waist circumference −3.1 (−5.7; -0.4) Fatigue (FACIT-F) N.S. 
Hip circumference N.S.   
weight N.S.   
 
Moadel, 2007 
[54] 
FACT  Overall QoL (FACT-G) P < 0.01† 
- Physical well-being N.S. - Social well-being ES = −0.22 (−3.78 to −0.36); P = 0.018 
- Functional well-being N.S. - Emotional well-being P = 0.018*; P < 0.05† 
Fatigue (FACT-fatigue) N.S. 
Spiritual well-being (FACIT Sp) P = 0.009† 
Distressed Mood (DMI) P < 0.05† 
- Anxious/sad P = 0.046† 
- Irritability P = 0.0275† 
- Confusion N.S. 
Raghavendra, 
2007 [49] 
Nausea frequency P = 0.01 Anxiety (STAI) P < 0.001 
Nausea severity P < 0.01 Depression (DBI) P < 0.001 
Vomiting frequency P = 0.06 Number of distressful symptoms P = 0.002 
Vomiting severity P = 0.05 Severity of symptoms P < 0.001 
Total toxicity score P < 0.001 Symptom distress P < 0.001 
Overall quality of life (FLIC) P < 0.001 
Rao, 2009 [50]   State anxiety (STAI) ES = 0.33; P < 0.05 (ITT) 
Trait anxiety (STAI) ES = 0.24; NS (ITT) 
Symptom distress P = 0.001 
Vadiraja, 2009a 
[46] 
Cortisol level at 6 am ES = 0.24;P < 0.05 Anxiety (HADS-A) ES = 0.31; P < 0.001 
Cortisol level at 9 am N.S. Depression (HADS-D) ES = 0.31; P < 0.01 
Cortisol level at 9 pm N.S. perceived stress (PSS) ES = 0.36; P < 0.001 
Mean pooled diurnal cortisol ES = 0.27; P < 0.05   
Vadiraja, 2009b 
[47] 
EORTC QLQ-C30  Positive Affect (PANAS) ES = 0.59; P = 0.007 
- Physical function ES = 0.16; N.S. Negative Affect (PANAS) ES = 0.84; P = 0.001 
HRQoL (EORTC QLQ-C30)  
- Role function ES = 0.19; N.S. 
- Emotional function ES = 0.71; P = 0.001 
- Cognitive function ES = 0.48; P = 0.03 
- Social function ES = 0.21; N.S. 
 
Vadiraja 2009c 
[48] 
Physical distress (RSCL) ES = 0.33; p = 0.02 Psychological distress (RCSL) ES = 0.39; p < 0.001 
EORTC-QLQ-C30  EORTC QLQ-C30  
- pain ES = 0.14; N.S. - fatigue ES = 0.33; N.S. 
- nausea and vomiting ES = 0.05; N.S. - insomnia ES = 0.47; N.S. 
- dyspnea ES = 0.01; N.S.   
- appetite loss ES = 0.38; N.S.   
- diarrhea ES = 0.01; N.S.   
- constipation ES = 0.14; N.S.   
Activity level ES = 0.14; N.S.   
BDI = Beck’s Depression Inventory; BFI = Brief Fatigue Inventory; CES-D = Centers for Epidemiologic Studies-Depression; CT = chemotherapy; DMI = Distressed 
Mood Index; EORTC-QoL C30 = European Organization for the Research and Treatment of Cancer-Quality of Life; ES = effect size; FACT-G = Functional 
Assessment of Cancer Therapy-General; FACIT = Functional Assessment of Chronic Illness Therapy; FLIC = Functional Living Index for Cancer; FSI = Fatigue 
Symptom Inventory; HADS = Hospital Anxiety and Depression Scale; IES = Impact of Events Scale; ITT = Intention to treat; LSI = Leisure Score Index; MAQ = 
Modifiable Activity Questionnaire; NA = not assessed; N.S. = not significant; PANAS = Positive and Negative Effect Schedule; POMS = Profile of Mood states; 
PSQI = Pittsburgh Sleep Quality Index; PSS = perceived stress scale; RSCL = Rotterdam Symptom Check List; SOSI = Symptoms of Stress Inventory; STAI = 
Spielberger’s State Trait Anxiety Inventory. 
Quality assessment 
Results of the methodological quality assessment are presented in Table 4. Median quality 
score was 67% (range 22–89%). All but one study [31] were of high quality. All included 
studies used randomization. In all but one [31] study treatment allocation was concealed, and 
groups were comparable at baseline, or dissimilarities at baseline were adequately adjusted 
for in the analyses. All studies adequately specified the eligibility criteria of the study 
population. The outcome assessor was blinded in five papers [32,51,52,57,58], but this 
criterion was not applicable in the seven papers using self-reported outcomes only 
[44,47,49,50,55]. In five papers [51,52,55-57], the yoga instructor was blinded as he or she 
was unaware of the study aim. Participants were blinded in two papers [51,58]; Banerjee [51] 
informed us that their study was double blinded. In four papers, point estimates and 95% 
confidence intervals (CI) for between group differences were reported [47,50,54,58]. One 
paper [44] reported 95% CI only, and three papers [46,48,55] only presented effect sizes, 
without 95% CI. In nine papers [32,47,48,50,52-55,58], data were analyzed on an intention-
to-treat basis. 
Table 4 Quality assessment sorted by study population and quality score 
First author, year 1 2 3 4a 5 6 7 8 9 score % 
Banasik, 2011 [56] Y Y Y Y SR Y C N N N 5 63% 
Banerjee, 2007 [51] Y Y C Y Y Y Y C Y C N N 7 78% 
Blank, 2003 [31] Y ? ? Y N ? N N N 2 22% 
Bower, 2012 [58] Y Y Y Y Y ? Y Y Y 8 89% 
Carson, 2009 [32] Y Y Y Y Y N C N N Y 6 67% 
Chandwani, 2010 [55] Y Y C Y Y SR Y C N N, ES no CI Y 6 75% 
Cohen, 2004 [44] Y Y Y Y NC (SR) N C N N, only 95% CI N 4 50% 
Culos-Reed, 2006 [52] Y Y Y Y Y C Y C N N Y 7 78% 
Danhauer, 2009 [53] Y Y Y Y NC N C N N Y 5 56% 
Littman, 2011 [57] Y Y C Y Y Y C Y d N Y N 7 78% 
Moadel, 2007 [54] Y Y C Y b Y NC N C N Y Y 6 67% 
Raghavendra, 2007 [49] Y Y Y Y SR N N N N 4 50% 
Rao, 2009 [50] Y Y Y Y SR N N Y Y 6 67% 
Vadiraja, 2009a [46] Y Y Y Y ? ? N N, ES no CI N 4 50% 
Vadiraja, 2009b [47] Y Y Y Y SR ? N Y Y 6 75% 
Vadiraja, 2009c [48] Y Y Y Y SR ? N N, ES no CI Y 5 56% 
NA not applicable, Y yes, N no, ? unclear, a If only exclusion criteria were reported, this was rated as ‘unclear’; b In the analyses, the baseline differences were 
included as covariates. C after contacting authors; d Yoga instructors were aware that the study aim was to determine the feasibility of conducting a yoga intervention 
in overweight and obese breast cancer survivors (not efficacy). SR self report, CI Confidence interval, ES effect size 
Study population 
Details of the study populations are reported in Table 1. Twelve studies included patients 
with breast cancer and one study focused on patients with lymphomas [44]. Five studies in 
patients with breast cancer studies took place during cancer treatment: three studies (five 
papers [46-48,51,55]) during radiotherapy, one study [31] during hormone therapy, and one 
study (two papers, [49,50]) during chemotherapy with or without additional radiotherapy. 
Five studies [32,52,56-58] focused on breast cancer survivors who had completed treatment, 
and two studies [53,54] included patients and survivors both during and after treatment. The 
study in patients with lymphomas included patients during and after active treatment [44]. 
Sample sizes ranged from 18 to 128 patients, with seven studies including less than 50 
patients, and only one study with more than 100 patients. Average age of the participants 
ranged from 44 to 63 years. One study did not report the age of the patients [50]. Eleven 
studies in patient with breast cancer included women only, one study [52] in mainly breast 
cancer patients (85%) included 5% men, and the study in lymphoma patients [44] included 
39% men. 
Yoga program 
The content of the yoga programs is summarized in Table 2. All included a supervised yoga 
program with physical poses (yoga asanas), combined with breathing techniques (pranayama) 
and relaxation or meditation (savasana or dhanya). 
All yoga classes were led by experienced yoga instructors. Median program duration was 
seven weeks with a range of six weeks to six months. In the study by Rao et al. [50], the 
program duration depended on the number of chemotherapy cycles, which ranged from four 
to eight. In this latter study, supervised sessions were conducted for 30 min before 
chemotherapy once every ten days. Furthermore, patients were provided with audiotapes of 
the exercises for home practice and asked to practice 1 h daily for 6 days/week during 
intervals between chemotherapy cycles [49]. In general, the number of classes per week 
ranged from one to three, and home practice was encouraged in nine studies, supported by 
audio or videotapes. Session duration ranged from 30 to 120 min; three studies did not report 
the session duration [31,44,50]. 
In nine studies [31,32,44,52-57] the yoga program was compared with a wait-list control 
group. In three studies [46-51], the control group received supportive therapy with education, 
counseling, or coping preparation. In one study, the control group received health education 
classes [58]. 
Effects 
Tables 5 and 6 present an overview of the effects of yoga on physical and psychosocial 
outcomes, respectively (for details, see Table 3). Fourteen papers reported on both physical 
and psychosocial outcomes, and two papers reported on psychosocial outcomes only. 
Table 5 Summary of the effects of yoga compared to control on physical outcomes 
PHYSICAL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Reference [56] [51] [31] [58] [32] [55] [44] [52] [53] [57] [54] [49] [50] [46] [47] [48] 
Year 2011 2007 2003 2011 2009 2010 2004 2006 2009 2011 2007 2007 2009 2009a 2009b 2009c 
Sample size 18 58 18 31 37 61 39 38 44 63 128 62 98 88 88 88 
Treatment AT RT HT AT AT RT Mix AT Mix AT mix CT CT + RT RT RT RT 
Quality high high low high high high high high high high high high high high high high 
Physical function                 
Physical function N.S.     ↑  N.S. N.S. N.S. N.S.    N.S.  
Functional well being N.S.        N.S. N.S. N.S.      
Physical symptoms                 
Pain     ↓ N.S.  N.S.        N.S. 
Nausea vomiting        N.S.    ↓    N.S. 
Toxicity            ↓     
Diarrhoea        ↓        N.S. 
Constipation        N.S.        N.S. 
Appetite        N.S.        N.S. 
Dyspnea        ↓        N.S 
Hot flashes     ↓            
Night sweats     N.S.            
Activity/fitness                 
Physical Activity        N.S.  N.S.      N.S. 
Weight        N.S.  N.S.       
Body mass index          N.S.       
Waist circumference          ↓       
Hip circumference          N.S.       
Flexibility    N.S.    N.S.         
Strength    N.S.    N.S.         
Fitness/distance walked        N.S.         
Perceived exertion        N.S.         
Biological Variables                 
DNA Damage  ↓               
Cortisol ↓             ↓   
Blood pressure        N.S.         
↑ = increase after yoga compared to control; ↓ decrease after yoga compared to control; N.S. no significant differences between yoga and control 
AT after treatment, CT chemotherapy, HT, hormonal therapy, RT radiotherapy, mix mixed group of patients during and after treatment 
Table 6 Summary of the effects of yoga compared to control on psychosocial outcomes 
PSYCHOSOCIAL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Reference [56] [51] [31] [58] [32] [55] [44] [52] [53] [57] [54] [49] [50] [46] [47] [48] 
Year 2011 2007 2003 2011 2009 2010 2004 2006 2009 2011 2007 2007 2009 2009a 2009b 2009c 
Sample size 18 58 18 31 37 61 39 38 44 63 128 62 98 88 88 88 
Treatment AT RT HT AT AT RT Mix AT Mix AT Mix CT CT + RT RT RT RT 
Quality high high low high high high High high high high high high high high high high 
Distress  ↓ ↓ N.S. ↓ N.S. N.S.     ↓ ↓ ↓  ↓ 
Anxiety  ↓ ↓   N.S. N.S.    ↓ ↓ ↓ ↓   
Depression  ↓  ↓  N.S. N.S.  ↓   ↓  ↓  N.S. 
Fatigue ↓   ↓ ↓ N.S. N.S.  N.S. N.S. N.S.      
Sleep disturbance    N.S. ↓ N.S. ↓  N.S.       ↓ 
General HRQoL ↑     ↑  ↑ ↑ N.S. ↑ ↑     
Emotional function N.S.     N.S.   ↑ N.S. ↑    ↑  
Social function N.S.     N.S.  N.S. N.S. N.S. ↑    N.S.  
Role function      N.S.         N.S.  
Cognitive function               ↑  
Positive affect         ↑      ↑  
Negative affect         ↑      ↑  
Vigor    ↑ ↑            
Mood   ↑  ↑            
Anger-hostility           ↓      
Spirituality         ↑  ↑      
Relaxation   ↑  ↑            
Confusion           N.S.      
Mental Health      N.S.   ↑        
Acceptance     ↑            
↑ = increase after yoga compared to control; ↓ decrease after yoga compared to control; N.S. no significant differences between yoga and control 
AT after treatment, CT chemotherapy, HT hormonal therapy, RT radiotherapy, mix, mixed group of patients during and after treatment 
Physical outcomes 
Twenty-three physical outcomes were examined in thirteen of the included papers (Table 5). 
In addition to self-reported physical function and functional well-being, outcomes included 
nine physical symptoms (e.g., pain, nausea, and dyspnoea), nine measures of physical activity 
and fitness, and three biological variables. However, except for physical function, functional 
well being, and pain, the outcomes were studied in only three studies or less, thus we 
considered this evidence insufficient to draw conclusions on the effectiveness of yoga on 
these outcomes. After excluding an outlier [55], the pooled effect size of yoga on physical 
function in patients with breast cancer was small and insignificant (d = 0.17; 95% CI = −0.06 
to 0.40), see Table 7. Further, in patients with breast cancer, yoga resulted in a small but 
significant increase in functional well-being (d = 0.31; 95% CI = 0.04 to 0.58). Pain was 
evaluated in four studies, of which standard deviations to calculate effect sizes were not 
available in two studies [32,44]. The average effect size of the other two studies among 
patients with breast cancer [48,55] was large (d = −0.64; 95% CI = −0.98 to −0.31). 
Table 7 Pooled effects of yoga on physical and psychosocial outcomes in patients with breast cancer 
Outcome # studies Pooled Effect    Test of heterogeneity   
Physical outcomes  d 95% CI Z P I2 Q P 
Physical function 6 0.60 −0.05 to 1.25 1.81 0.07 87.51 40.03 <0.0001 
 5a 0.17 −0.06 to 0.40 1.48 0.14 0.00 1.20 0.88 
Functional well-being 4 0.31 0.04 to 0.58 2.24 0.03 0.00 1.25 0.74 
Psychosocial outcomes  d 95% CI Z P I2 Q P 
Distress 7 −0.95 −1.49 to −0.49 −4.04 <0.001 80.79 31.24 <0.001 
 6b −0.75 −1.09 to −0.42 −4.39 <0.001 59.59 12.37 0.03 
Anxiety 7 −1.25 −1.93 to −0.56 −3.64 <0.001 91.45 70.20 <0.001 
 6b −0.77 −1.08 to −0.46 −4.86 <0.001 58.42 12.03 0.03 
Depression 7 −1.47 −2.42 to −0.53 −3.05 0.002 93.29 89.46 <0.001 
 6b −0.69 −1.02 to −0.37 −4.21 <0.001 42.15 8.64 0.12 
Fatigue 7 −0.51 −0.79 to −0.22 −3.46 0.001 43.52 10.62 0.10 
Sleep disturbance 4 −0.26 −0.53 to 0.02 −1.82 0.07 0.00 1.25 0.74 
General HRQoL 7 0.88 0.25 to 1.50 2.75 0.006 86.49 44.41 <0.001 
 6a 0.61 0.16 to 1.06 2.50 0.008 69.79 16.55 0.005 
 5a,c 0.37 0.11 to 0.62 2.85 0.004 0.00 3.40 0.49 
Emotional function 5 0.49 0.16 to 0.81 2.93 0.003 26.58 5.45 0.24 
Social function 6 0.33 0.12 to 0.54 3.12 0.002 0.00 1.94 0.86 
a
 Excluding outlier Chandwani et al. 2010 [55]; b Excluding outlier Banerjee et al. [51]. c Excluding outlier Raghavendra et al. 2007 [49] 
Psychosocial outcomes 
Twenty psychosocial outcomes were examined in the fifteen included papers (Table 6). The 
effects of yoga on distress, anxiety, depression, fatigue, sleep, general QoL, emotional 
function and social function were evaluated in three or more studies. After excluding outliers, 
yoga resulted in significant large reductions in distress (d = −0.75; 95% CI = −1.09 to −0.42), 
anxiety (d = −0.77; 95% CI = −1.08 to −0.46), and depression (d = −0.69; 95% CI = −1.02 to 
−0.37), moderate reductions in fatigue (d = −0.51; 95% CI = −0.79 to −0.22), and moderate 
increases in general HRQoL (d = 0.37; 95% CI = 0.11 to 0.62), emotional function (d = 0.49; 
95% CI = 0.16 to 0.81), and social function (d = 0.33; 95% CI = 0.12 to 0.54) in breast cancer 
patients, see Table 7. Effects on sleep disturbances were small and insignificant (d = −0.26; 
95% CI = −0.53 to 0.02). In patients with lymphoma, however, Cohen et al. [44] found a 
significant reduction in sleep disturbances (d = −1.00; 95% CI = −3.8 to −0.8). Although 
some studies found beneficial effects on other psychosocial outcomes, including positive and 
negative effect, mood, spirituality and relaxation (Table 6), these were studied in less than 
three studies. Therefore, this evidence was considered to be insufficient. 
Dropout and attendance 
Dropout from the studies, defined as the number of randomized participants without post-
intervention measurement ranged from 0 to 38%. Attendance at the yoga classes was reported 
in nine studies [32,44,47,53-57], and varied between 58 and 88% (Table 2). Vadiraja et al. 
[47] reported that the level of adherence did not influence results on QoL, positive and 
negative affect [47]. Four other studies reported on the influence of intervention adherence on 
outcomes. Danhauer et al. [53] reported that better intervention adherence was associated 
with higher self-reported physical function and QoL. In contrast, Moadel et al. [54] found 
similar improvements in QoL among participants with low and high class attendance, but 
found a positive association between intervention attendance and improved mood. Carson et 
al. [32] also showed that greater mean yoga practice time was associated with less fatigue, 
less symptom bother, and more acceptance at post-treatment, and tended to be associated 
with less sleep disturbances. Littman et al. [57] reported that generally, the benefits were 
greater among women who attended more facility-based classes, but results were not entirely 
consistent. 
Safety 
Five studies evaluated adverse events and provided this information in the manuscripts 
[47,50,53,57,58]. Four studies reported that there were no adverse events and one study [58] 
reported one adverse event of a participant with a history of back problems, who experienced 
a back spasm in yoga class. After evaluation by her physician, she was able to return to class 
and complete the intervention. 
Discussion 
This review and meta-analysis described and evaluated sixteen papers examining yoga as an 
intervention to manage physical and psychosocial symptoms in cancer patients and survivors. 
In contrast to previous reviews [35,36] and meta-analysis [37] we only included studies 
focusing on yoga interventions with physical postures, and evaluating the effectiveness on 
physical and/or psychosocial outcomes. Yoga appeared to be a feasible intervention, and 
beneficial effects on several physical and psychosocial symptoms were reported, with a small 
effect on functional well-being and moderate to large effects on various psychosocial 
outcomes. 
Physical outcomes 
Due to the limited number of studies per physical outcome, evidence for physical effects of 
yoga was generally insufficient to draw firm conclusions. The effects of yoga on physical 
function and functional well-being were small. This may be related to the short intervention 
duration; only two studies lasted 12 weeks or longer [54,57], all others were shorter, ranging 
from 6 to 10 weeks (median = 7). To improve physical function and fitness, longer 
intervention duration may be required. The lack of significant improvements in physical 
function and fitness may also be related to the relatively low intensity of certain types of yoga 
[52,59]. Nevertheless, in healthy older adults, a 6-month yoga intervention resulted in 
improved physical outcomes such as timed 1-leg stand, flexibility, and energy [60]. These 
beneficial effects may be related to the lower baseline cardiorespiratory fitness of older adults 
compared with younger patients, and the longer intervention duration in that specific study. 
Significant improvements in treadmill time and estimated peak oxygen uptake as a result of 
yoga have also been shown in a small group of patients with chronic heart failure [61]. A 
systematic review of studies comparing yoga with other forms of exercise concluded that in 
both healthy people and in patients with chronic diseases, yoga may be as effective or better 
than other forms of exercise at improving a variety of health-related outcome measures, 
including physical outcomes such as muscle strength and flexibility [34]. One study with 
healthy sedentary elderly people has reported that peak oxygen uptake increased by 11% after 
yoga, compared with 24% after aerobic training [62]. Although patients perceived that they 
had improved fitness after 12 weeks of yoga [63], future empirical evidence should indicate 
whether yoga is as beneficial as endurance or strength exercise in improving physical fitness 
in (physically inactive) cancer patients. 
Psychosocial outcomes 
This review found that yoga has large beneficial effects on distress, anxiety and depression, 
moderate beneficial effects on fatigue, general HRQoL, emotional function and social 
function, and a small and insignificant effect on sleep. There was insufficient evidence for 
effects on psychosocial outcomes that were studied less frequently including cognitive 
function, vigor, anger-hostility, spirituality, relaxation and mental health. More studies 
evaluating the effects of yoga on these outcomes are needed before we can draw firm 
conclusions. 
The finding that yoga improves QoL, and reduces distress and depression concurs with 
findings from previous reviews and meta-analysis of yoga interventions for cancer patients 
and survivors [35,37]. In contrast, the current meta-analysis could not confirm previous 
findings on reductions in sleep disturbances in patients with breast cancer. Fatigue is among 
the most frequently occurring and debilitating complaints associated with cancer and cancer 
treatments [5,64]. Therefore, it is important to find effective strategies to reduce fatigue in 
cancer patients. In contrast to the meta-analysis of Lin et al. [37], we found a moderate 
significant effect size on fatigue. This is in line with a recent study of Bower et al. [58] who 
showed beneficial effects after 12 weeks of yoga classes on persistent fatigue in breast cancer 
survivors. In addition, patients themselves also perceived improvements in QoL, fatigue, 
stress, anxiety and depression [63]. The moderate-to-large effect sizes on these psychosocial 
outcomes seem larger than the small to moderate effect sizes of exercise [12,16,65-67] or 
psychosocial interventions [12,66,68]. However, our results have to be interpreted with 
caution due to small sample sizes in most studies. Furthermore effect sizes may also be 
influenced by patient selection, i.e. including also non-fatigued or non-depressed patients. 
Therefore, future studies should obtain insight in the most effective interventions to improve 
psychosocial outcomes. The current meta-analysis showed that yoga may be such an 
intervention. 
Methodological quality of studies 
This review included a quality rating, and only one paper was of low quality. A major 
concern regarding the methodological quality of most included studies was that not all 
participants completed the yoga program and data were not analysed on an intention-to-treat 
basis. This may have introduced bias, overestimating the benefits of yoga. Only half of the 
studies reported class attendance, of which four studies indicated that intervention adherence 
was positively associated with some outcomes [32,53,54,57]. Whether adherence to the yoga 
sessions was affected by cancer-related symptoms or side-effects of cancer treatment was not 
reported. 
Most studies separately reported the descriptive results of the outcomes for the yoga and 
control groups, and presented only p-values for the group differences. Many studies however, 
did not report effect sizes or other point estimates of the between-group differences, and their 
confidence intervals. Therefore we calculated standardized mean differences using means and 
standard deviations of the post-test values. 
Furthermore, as with all exercise interventions, blinding was difficult. Because the control 
group usually consisted of either wait-list or usual care, participants were not blinded to the 
intervention, possibly introducing bias. 
Strengths and limitations 
The extensive search in ten databases, the inclusion of RCTs, the methodological quality 
assessment and conduction of a meta-analysis are strengths of the study. Further, by only 
including studies focusing on yoga interventions that contained physical postures (asanas), 
we attempted to reduce the variability between the yoga interventions, thereby increasing the 
comparability of studies. Nevertheless, there may still remain some variability between the 
different types of yoga interventions included in this review. This may be reflected by the 
high heterogeneity. Other sources of high heterogeneity may be differences in instruments 
used to define the outcome, differences in patient groups (i.e. different stage of cancer, or 
different timing of the intervention with respect to primary cancer treatment), or differences 
in control groups. Because of the small number of studies, we were unable to conduct 
subgroup analyses to further reduce heterogeneity. Although we used random effects 
modelling to take into account the large heterogeneity, overall effect sizes should be 
interpreted with caution as they may vary somewhat among subgroups. 
In general, publication bias endangers the external validity of reviews and meta-analyses. 
Also in this study, publication bias cannot be ruled out. Another limitation is the small 
sample size of some studies. In addition, some studies were conducted by the same research 
group, and other studies had multiple outcomes, increasing the probability of type 1 errors. 
Furthermore, most studies offered yoga to people based on having cancer, not based on 
having physical or psychosocial problems, which may have resulted in an underestimation of 
the beneficial effects of yoga. 
The yoga interventions were conducted during various forms of cancer treatment; some were 
conducted post-treatment, and some studies included a mixed sample of patients during and 
post-treatment. Due to the limited number of studies, it is difficult to draw conclusions on the 
optimal timing for yoga interventions. Future studies should consider this issue. 
Further, although effect sizes for many psychosocial outcomes were generally moderate to 
large, effect sizes of yoga interventions on physical function and functional well-being were 
small. This may indicate that the effect is small, or that some patients may have physical 
benefits from yoga whereas others may not, which may be indicative of the heterogeneity of 
cancer patients. Future studies with large sample sizes should identify moderators of the 
effect of yoga on physical and psychosocial outcomes in order to identify subgroups of 
patients whom may specifically benefit from yoga. 
Finally, this review only included papers published in the English language. Although our 
searches were not limited to language, we may have missed important findings from yoga in 
Asia, in which practicing yoga is much more common than in Western countries. 
Nevertheless, this review included six studies that were conducted in Asia. 
Clinical implications 
The emerging literature provides preliminary support for the feasibility and efficacy of yoga 
interventions for cancer patients. Only one adverse effect was reported in five studies that 
assessed adverse events, and the results indicate that yoga may improve physical well-being 
and psychosocial outcomes. Although the literature suggests yoga may be effective in 
improving physical outcomes in other patients and healthy elderly [29,30,34], evidence in 
cancer patients and survivors is generally insufficient to draw firm conclusions at this stage. 
In contrast, physical exercise has been shown to be effective in improving physical function 
and fitness in cancer patients and survivors [3,4,10,16]. However, for cancer patients and 
survivors who are unable or unwilling to participate in traditional aerobic or resistance 
exercise programs yoga may be an appropriate form of exercise [63] as it is especially 
suitable for those who perceive barriers to other forms of exercise [69]. Breast cancer patients 
have been found to perceive more barriers to exercise than age-matched controls, and higher 
barriers were associated with less exercise [70]. In a recent pilot study, breast cancer 
survivors reported minimal barriers and high motivation for participating in a yoga program 
[63]. All participants reported that yoga was beneficial and enjoyable, that they were 
confident that they could do the exercises, and that they were motivated to attend all classes 
[63]. However, evidence for yoga as an effective intervention to improve physical function 
and fitness is lacking and should be established by future studies. Future studies should also 
systematically assess and report adverse events related to yoga. 
Conclusion 
This systematic review and meta-analysis of RCTs showed that yoga has strong beneficial 
effects on distress, anxiety and depression, moderate effects on fatigue, general HRQoL, 
emotional function and social function, small effects on functional well-being, and no 
significant effects on physical function and sleep disturbances. Results of the current review 
must be interpreted with caution due to the relative small sample sizes of most of the included 
studies. RCTs with larger sample sizes are needed to improve our understanding of the 
physical and psychosocial effects of yoga. Future studies should also address the optimal 
duration and frequency of yoga, the effects in patients with types of cancer other than breast 
cancer, and the optimal time point in the cancer and cancer treatment or rehabilitation 
trajectories for offering yoga interventions [63]. 
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